|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2006;81:1181-1182
© 2006 The Society of Thoracic Surgeons
Division of Thoracic Surgery, Massachusetts General Hospital, 55 Fruit St, Blake 1570, Boston, MA 02114
(Email: wright.cameron@mgh.harvard.edu).
| The first 20% of the full text of this article appears below. |
To the Editor:
The conclusions we drew from our admittedly rather modest data set of the role of radiation therapy (RT) in stage III thymomas were conservative and meant to be provocative and simulate further studies. We believe these conclusions are still valid. Dr Cesaretti [1] has added yet another reference (Zhu and colleagues [2]) that supports our conclusions rather than his own. I thank Dr Cesaretti for picking up an error in proofreading; indeed the radiation dosimetry was from our stage II patients rather than our stage III patients. The correct dose was an average of 5,040 Gy (range, 25 to 64 Gy) with 20
Related Article
Ann. Thorac. Surg. 2006 81: 1180-1181.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |